Latest News and Press Releases

Dublin, Aug. 22, 2022 (GLOBE NEWSWIRE) -- The "Real World Evidence Solution Market Research Report by Component (Data Set and Services), Therapeutic Area, End-User, Region (Americas, Asia-Pacific,...

Dublin, Aug. 02, 2022 (GLOBE NEWSWIRE) -- The "Pharmacovigilance World 2022" conference has been added to ResearchAndMarkets.com's offering. With the augmented incidence of diseases, and the...

PRINCETON, N.J., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has licensed...

Dublin, Jan. 27, 2022 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Market Size, Share & Trends Analysis Report by Product Life Cycle, by Service Provider, by Type, by Process Flow, by Therapeutic...

Dublin, Nov. 08, 2021 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Training Course" conference has been added to ResearchAndMarkets.com's offering. This comprehensive three-day course has been...

Phoenix, AZ, Aug. 20, 2021 (GLOBE NEWSWIRE) -- The American College of Medical Toxicology’s Toxicology Investigators Consortium (ToxIC) has received several reports of patients who became ill from...

Dublin, July 21, 2021 (GLOBE NEWSWIRE) -- The "Trends: Hot Topic Catalyst" report has been added to ResearchAndMarkets.com's offering.Receipt of a CRL slows approval, causing increased costs and...

Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Training Course" conference has been added to ResearchAndMarkets.com's offering. This comprehensive three-day course has been...

PRINCETON, N.J., May 04, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of its Secondary Intelligence™ software, the first and...

Dublin, April 12, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmacovigilance and Drug Safety Software Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The publisher has...